¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lipo"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • lipopolysaccharide
    ÁöÁú´Ù´çÁú
  • lipoprotein
    ÁöÁú´Ü¹éÁú
  • lipoprotein lipase
    ÁöÁú´Ü¹éÁöÁúºÐÇØÈ¿¼Ò
  • liposarcoma
    Áö¹æÀ°Á¾
  • liposclerosis dermatitis
    Áö¹æ°æÈ­ÇǺο°
  • liposis
    Áö¹æÁ¾Áõ
  • liposoluble
    Áö¿ë¼º-
  • liposome
    Áö¹æ¼Òü, ¸®Æ÷¼Ø
  • liposuction
    Áö¹æÈíÀÎ(¼ú)
  • lipotrophy
    Áö¹æÁõ°¡(Áõ)
  • lipotropic
    1. Áö¹æÄ£È­-, Áö¹æÁ¦°Å- 2. Áö¹æ°£Á¦°ÅÁ¦
  • lipotropic agent
    Ä£Áö¹æÁ¦
  • lipotropy
    Áö¹æÄ£È­¼º, Ä£Áö¹æ¼º
  • lipoxeny
    ¼÷ÁÖȲÆóÈ­
  • lipoxidase
    Áö¹æ»êÈ­È¿¼Ò, ¸®Æø½Ã´ÙÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 13 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • lipoprotein
    ÁöÁú´Ü¹é
  • liposarcoma
    Áö¹æÀ°Á¾
  • liposclerosis dermatitis
    Áö¹æ°æÈ­ÇǺο°
  • liposis
    (¢¡lipomatosis) Áö¹æÁ¾Áõ
  • liposoluble
    Áö¿ë¼º-
  • liposome
    ¸®Æ÷¼Ø
  • liposuction
    Áö¹æÈíÀÎ(¼ú)
  • lipotrophy
    Áö¹æÁõ°¡Áõ
  • lipotropic
    Ä£Áö¹æ-, Ä£Áö¹æÁ¦
  • lipotropic agent
    Ä£Áö¹æ¾à
  • lipotropy
    Ä£Áö¹æ¼º
  • lipoxeny
    ¼÷ÁÖȲÆóÈ­
  • lipoxidase
    Áö¹æ»ê»êÈ­È¿¼Ò
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • lipoid metamorphosis
    ¸®Æ÷À̵庯Å (¡­Ü¨÷¾).
  • lipoid nephrosis
    ¸®Æ÷À̵å½ÅÁõ(¡­ãìñø), À¯ÁöÁú½ÅÁõ.
  • lipoid nephrosis
    À¯ÁöÁú ½ÅÁõ, ¹Ì¼Òº´º¯ ½ÅÁõÈıº(Ú°á³Ü»Ü¨ ãìñøý¦ÏØ)
  • lipoid nodule
    À¯Áö¹æ °áÀý
  • lipoid pleurisy
    ¸®Æ÷À̵åÈ丷¿°(¡­ýØØ¯æú), À¯ÁöÁúÈ丷¿°.
  • lipoid pneumonia
    ¸®Æ÷À̵åÆó·Å, À¯ÁöÁúÆó·Å(¡­øËæú).
  • lipoid proteinosis
    À¯Áö¹æ¼º´Ü¹éÁõ
  • lipoid theory
    ¸®Æ÷À̵弳, À¯ÁöÁú¼³.
  • lipoidase
    ¸®Æ÷ÀÌ´ÙÁ¦.
  • lipoidemia
    ¸®Æ÷À̵åÇ÷Áõ, À¯ÁöÁúÇ÷Áõ.
  • lipoidocalcinosis
    ¸®Æ÷À̵弮ȸÁõ(¡­à´üéñø), À¯ÁöÁú¼®È¸Áõ.
  • lipoidolytic
    ¸®Æ÷À̵åºÐÇØ¼º(¡­ÝÂú°àõ)(ÀÇ).
  • lipoidosis
    ¸®Æ÷À̵åÁõ, À¯ÁöÁúÁõ.
  • lipoidproteinosis
    ¸®Æ÷À̵å´Ü¹éÁõ.
  • lipoidsiderosis
    Áö¹æÃ¶Áõ(¡­ôÑñø), À¯ÁöÁúöÃàÀû.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
lipogenesis The production of fat, either fatty degeneration or fatty infiltration; also applied to the normal deposition of fat or to the conversion of carbohydrate or protein to fat.
Synonym: adipogenesis.
Origin: Lipo-+ G. Genesis, production
(05 Mar 2000)
lipogenic Relating to lipogenesis.
Synonym: adipogenic, adipogenous, lipogenous.
(05 Mar 2000)
lipogenous Relating to lipogenesis.
Synonym: adipogenic, adipogenous, lipogenous.
(05 Mar 2000)
lipogenous diabetes Diabetes and obesity combined.
(05 Mar 2000)
lipogranuloma A nodule or focus of granulomatous inflammation (usually of the foreign-body type) in association with lipid material deposited in tissues, e.g., after the injection of certain oils.
See: paraffinoma.
Synonym: eleoma, oil tumour, oleogranuloma, oleoma.
(05 Mar 2000)
lipogranulomatosis 1. Presence of lipogranulomas.
2. Local inflammatory reaction to necrosis of adipose tissue.
Disseminated lipogranulomatosis, a form of mucolipodosis, developing soon after birth because of deficiency of ceramidase; characterised by swollen joints, subcutaneous nodules, lymphadenopathy, and accumulation in lysosomes of affected cells of PAS-positive lipid consisting of ceramide.
Synonym: Farber's disease, Farber's syndrome.
(05 Mar 2000)
lipohemia An obsolete term for lipaemia.
(05 Mar 2000)
lipoic acid <biochemistry> 1,2 dithiolane 3 valeric acid. Regarded as a coenzyme in the oxoglutarate dehydrogenase complex of the citric acid cycle. Involved generally in oxidative decarboxylations of _ keto acids. A growth factor for some organisms.
(18 Nov 1997)
lipoid 1. Resembling fat.
2. Former term for lipid.
Synonym: adipoid.
Origin: Lipo-+ G. Eidos, appearance
(05 Mar 2000)
lipoid granuloma Granuloma characterised by aggregates or accumulations of fairly large mononuclear phagocytes that contain lipid.
(05 Mar 2000)
lipoid nephrosis <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure. This disorder is one common cause of nephrotic syndrome in children affecting 2 to 3 children per 100,000 population under age 16 in the us. Minimal change disease is also seen rarely in adults.
The cause is unknown but may be related to an autoimmune illness. Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy. Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
(27 Sep 1997)
lipoid proteinosis <disease> A familial disease occurring in the course of latent diabetes, marked by yellowish nodules due to deposits of a protein-lipid complex on the oral tongue and sublingual and faucial areas, translucent keratotic papillomatous eyelid lesions, keratotic lesions on the extremities, and hoarseness.
It is due to a disturbance of lipid metabolism with autosomal recessive inheritance and is frequently associated with intracranial calcifications.
inheritance: autosomal recessive.
Synonym: hyalinasis cutis et mucosae, lipoidosis cutis et mucosae, Urbach-Wiethe disease.
(05 Mar 2000)
lipoid theory of narcosis That narcotic efficiency parallels the coefficient of partition between oil and water, and that lipoids in the cell and on the cell membrane absorb the drug because of this affinity.
Synonym: Meyer-Overton theory of narcosis.
(05 Mar 2000)
lipoidemia <biochemistry> Presence of an abnormally high amount of lipid in the bloodstream.
Origin: Gr. Haima = blood
(18 Nov 1997)
lipoidosis A disturbance of lipid metabolism with abnormal deposit of lipids in the cells.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 4
  • Lipoproteins, HDL - »õâ A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases.
    Synonyms : Heavy Lipoproteins, alpha-1 Lipoprotein, HDL Lipoproteins, High Density Lipoproteins, Lipoproteins, Heavy, Lipoproteins, High-Density, alpha Lipoproteins
  • Lipoproteins, HDL2 - »õâ Low-density subclass of the high-density lipoproteins, with particle sizes between 8 to 13 nm.
    Synonyms : HDL-2, HDL2 Lipoprotein, High Density Lipoprotein HDL2, Lipoprotein HDL2, HDL 2, HDL2 Lipoproteins, HDL2, Lipoprotein, High Density Lipoprotein 2, Lipoprotein, HDL2
  • Lipoproteins, HDL3 - »õâ Intermediate-density subclass of the high-density lipoproteins, with particle sizes between 7 to 8 nm. As the larger lighter HDL2 lipoprotein, HDL3 lipoprotein is lipid-rich.
    Synonyms : HDL-3, HDL3 Lipoprotein, High Density Lipoprotein HDL3, Lipoprotein HDL3, HDL3 Lipoproteins, High Density Lipoprotein 3, Lipoprotein, HDL3
  • Lipoproteins, IDL - »õâ A mixture of very-low-density lipoproteins (VLDL), particularly the triglyceride-poor VLDL, with slow diffuse electrophoretic mobilities in the beta and alpha2 regions which are similar to that of beta-lipoproteins (LDL) or alpha-lipoproteins (HDL). They can be intermediate (remnant) lipoproteins in the de-lipidation process, or remnants of mutant CHYLOMICRONS and VERY-LOW-DENSITY LIPOPROTEINS which cannot be metabolized completely as seen in FAMILIAL DYSBETALIPOPROTEINEMIA.
    Synonyms : Broad-beta Lipoproteins, Floating beta-Lipoproteins, Intermediate Density Lipoproteins, Intermediate-Density Lipoproteins, Lipoprotein, IDL, Lipoproteins, Intermediate Density, alpha2-VLDL, alpha2-VLDL Lipoprotein, beta-VLDL, beta-VLDL Lipoproteins, alpha2 VLDL
  • Lipoproteins, LDL - »õâ A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues.
    Synonyms : LDL(1), LDL(2), LDL-1, LDL-2, LDL1, LDL2, Low-Density Lipoprotein 1, Low-Density Lipoprotein 2, LDL Lipoproteins, Lipoproteins, Low-Density, Low Density Lipoprotein 1, Low Density Lipoprotein 2, Low Density Lipoproteins, beta Lipoproteins
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
lipoblastic (lipo
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
lipoarthritis (lipo
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
lipocatabolic (lipo
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
lipoblast (lipo
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
lipochromemia (lipo
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 4
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á